We are deeply grateful to Dr. Nagourney and his entire team at the Nagourney Cancer Institute for presenting the results of his latest study during the ASCO Annual Meeting this year. This exciting study offers hope for new and novel treatment options. See what was presented by Dr. Nagourney and his team at ASCO: https://ascopubs.org/doi/10.1200/JCO.2026.44.16_suppl.10041
The Nagourney Cancer Institute has been working tireless to learn about fibrolamellar and find promising treatment options for patients. Their latest breakthrough discovery shows a connection between fibrolamellar and cellular metabolism.
For our patients and families currently navigating a Fibrolamellar diagnosis, we would like to extend an open invitation: whenever you are traveling to Southern California, you are welcome to receive a complete metabolic panel as part of this IRB-approved study. This test is performed at the Nagourney Cancer Institute at no cost to the patient.
Please reach out to us at contactus@fibrofighters.org to learn more.
Dr. Robert Nagourney (left) and a member of his research team, Sabina Schneider (middle), presenting their findings at ASCO. They met with Dr. Paul Kent (right) to discuss.